Journals / Turkish Journal of Hematology / 2007 / Cilt: 24 - Sayı: 1

Serebral infarktlı Türk çocuklarında seratonin (5-HT) 2A reseptör genindeki T102C polimorfizmi

T102C polymorphism of the serotonin (5-HT) 2A receptor gene in Turkish children with cerebral infarct

Pages
14–17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, this needs to be clarified with further studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Platelet-dependent thromboembolism is an underlying mechanism in the pathogenesis of stroke. 5-HT2A receptor gene is expressed in human platelet, coronary artery (blood vessels) and brain.
📊
Key Findings & Data:A polymorphism T102C at the 5-HT2A receptor gene was found that may possibly affect the 5-HT2A receptor function.
💡
Conclusion & Impact:However, this needs to be clarified with further studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Çocuk · Manyetik rezonans görüntüleme · Polimorfizm

Abstract

Platelet-dependent thromboembolism is an underlying mechanism in the pathogenesis of stroke. 5-HT2A receptor gene is expressed in human platelet, coronary artery (blood vessels) and brain. A polymorphism T102C at the 5-HT2A receptor gene was found that may possibly affect the 5-HT2A receptor function. As there is no existing data on T102C variant of 5-HT2A receptor gene in pediatric stroke, we aimed to study in this case-control study whether there is a association between this polymorphism and pediatric stroke. 111 patients (10 months-18 years old) with cerebral infarct and 79 healthy control was included to our study. Polymerase chain reaction (PCR) of the T102C alteration at the 5-HT 2A receptor gene was performed. Our data revealed that, 5-HT (2A) receptor T102C polymo phism was not associated with pediatric stroke in our population either alone or in combination with underlying pro thrombotic factors. However, this needs to be clarified with further studies.

Özet

5-HT2A reseptör genindeki T102C polimorfizmi muhtemelen bu reseptörün fonksiyonlarını etkilemektedir. Pediatrik inmede 5-HT2A reseptör genindeki T102C varyantı ile ilgili mevcut bilgi olmadığı için çalışmamızda; bu polimorfizm ile pediatrik inme arasında ilişki olup olmadığını araştırmayı amaçladık. Serebral inme öyküsü olan 111 çocuk (10 ay-18 yaş) ve 79 sağlıklı kontrol çalışmaya dâhil edildi. 5-HT2A reseptör genindeki T102C değişimi PCR tekniği ile çalışıldı. Sonuç olarak; bu polimorfizm ne tek başına ne de diğer altta yatan protrombotik faktörlerle birlikte değerlendirildiğinde pediatrik inme ile ilişkili bulunmadı, ne var ki bu bilgi daha sonraki çalışmalarla da aydınlatılmalıdır.

🔖

Cite This Article

DÖNMEZ, N. B., TEBER, S., DEDA, G., AKAR, N. (2007). Serebral infarktlı Türk çocuklarında seratonin (5-HT) 2A reseptör genindeki T102C polimorfizmi. Turkish Journal of Hematology, Cilt: 24 - Sayı: 1, 14–17. https://ajindex.com/articles/413221

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993; 8:250-5
  2. Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol 1993;8:201-20
  3. Akar N. Molecular approach to Turkish pediatric stroke patients. Turk J Hematol 2002;19:245-53
  4. Nowak-Gottl U, Strater R, Dübbers A, Oleszuk-Raschke K, Vielhaber H. Ischemic stroke in infancy and childhood: role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 1996;7:684-8
  5. Ganesan V, McShane MA, Liesner R. Inherited prothrombotic states and ischemic stroke in childhood. J Neurol Neurosurg Psychiatry 1998;65:508-11
  6. Akar N, Akar E, Deda G. Factor V 1691 G-A, prothrombin 20210G-A and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infart. J Child Neurol 1999;14:749-51
  7. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7
  8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703
  9. Akar N, Akar E, Dalgin G, Sozuoz A, Omurlu K, Cin S. Frequency of factor V 1691 (G-A) mutation in Turkish population. Thromb Haemost 1997;78:1527-8
  10. Akar N, Misirlioglu M, Akar E, Avcu F, Yalcin A, Sozuoz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998;58:249
  11. McColl MD, Chalmers EA, Thomas A, Sproul A, Healey C, Rafferty I, McWilliams R, Eunson P. Factor V Leiden, prothrombin 20210G􀀅A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999;81:690-4
  12. Nowak-Göttl U, Strater R, Heinecke A, Junker R, Koch H, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-82
  13. Kenet G, Sadetzki S, Murat H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-8
  14. Zenz W, Bodo Z, Plotho J, Streif W, Male C, Bernert G, Rauter